Cocoon Biotech

📍 Cambridge, United States🗓 Founded 2013👥 6 employees💰 Last funded Sep 2020
Biotechnology🌐 cocoonbiotech.com
Website LinkedIn
Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon’s first products are silk fibroin formulated with small molecules that target pain and inflammation in ophthalmology and osteoarthritis indications.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Cocoon Biotech?
Cocoon Biotech has 1 investors on record on gritt.io and 1 late-stage investors.
When did Cocoon Biotech last raise funding?
The most recent investment in Cocoon Biotech recorded on gritt.io was in September 2020.
When was Cocoon Biotech founded?
Cocoon Biotech was founded in 2013.
What industry is Cocoon Biotech in?
Cocoon Biotech operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cocoon Biotech based?
Cocoon Biotech is headquartered in Cambridge, United States.